A patient with dermatomyositis has developed interstitial lung disease and esophageal dysmotility. Which nursing intervention is most appropriate to address her current respiratory and nutritional complications?

B) Position the patient upright during meals to reduce the risk of aspiration and enhance breathing.

A) Encourage increased oral fluid intake to manage dysphagia and improve hydration.

B) Position the patient upright during meals to reduce the risk of aspiration and enhance breathing.

C) Implement a high-calorie, high-protein diet to address muscle inflammation and prevent malnutrition.

D) Educate the patient about energy conservation techniques to manage fatigue and shortness of breath.

A patient with dermatomyositis has developed interstitial lung disease and esophageal dysmotility. As the nurse, which intervention is most important to prioritize to prevent further complications in this patient?

C) Monitor oxygen saturation levels and report any further decrease immediately.

A) Encourage the patient to increase physical activity to improve muscle strength.

B) Educate the patient on small, frequent meals to aid in nutritional intake.

C) Monitor oxygen saturation levels and report any further decrease immediately.

D) Advise the patient to avoid lying down immediately after meals to prevent aspiration.

A patient with interstitial lung disease is undergoing treatment with IVIG and is experiencing persistent dysphagia and weight loss. Which nursing intervention is most important to prioritize to address the patient's current nutritional and respiratory needs?

B) Collaborate with the dietitian to create a high-calorie, soft diet plan

A) Encourage the patient to engage in daily respiratory exercises to improve lung capacity

B) Collaborate with the dietitian to create a high-calorie, soft diet plan

C) Monitor oxygen saturation levels closely and adjust oxygen therapy as needed

D) Educate the patient on swallowing techniques to prevent aspiration during meals

A patient undergoing treatment with intravenous immunoglobulin (IVIG) for muscle weakness and interstitial lung disease shows improvement in muscle strength and oxygen saturation, but continues to experience dysphagia and weight loss. As a nurse, what is the most appropriate initial intervention to address the patient's nutritional needs?

C) Collaborate with a dietitian to implement a soft diet with small, frequent meals.

A) Initiate a high-calorie, high-protein liquid diet via nasogastric tube.

B) Encourage the patient to consume large meals with high-calorie snacks.

C) Collaborate with a dietitian to implement a soft diet with small, frequent meals.

D) Request a consultation for total parenteral nutrition (TPN) to improve caloric intake.

A nurse is reviewing the care plan for a patient with interstitial lung disease and recent weight loss. Which intervention should the nurse prioritize to address both the patient's respiratory condition and nutritional status?

C) Collaborate with the nutritionist to incorporate high-calorie supplements into the diet.

A) Encourage deep breathing exercises to improve lung capacity.

B) Administer prescribed corticosteroids to reduce lung inflammation.

C) Collaborate with the nutritionist to incorporate high-calorie supplements into the diet.

D) Teach the patient energy conservation techniques to manage fatigue.

A patient with interstitial lung disease is experiencing increased fatigue, breathlessness on exertion, and a 7-pound weight loss over three weeks despite an improvement in muscle strength. Her oxygen saturation is 91% on room air, and a high-resolution CT scan shows subtle progression of interstitial changes. What is the nurse's priority intervention to address her current health status?

B) Collaborate with the multidisciplinary team to adjust the patient's immunosuppressive therapy to better control pulmonary symptoms.

A) Encourage the patient to perform more physical activities to improve her lung capacity and muscle strength.

B) Collaborate with the multidisciplinary team to adjust the patient's immunosuppressive therapy to better control pulmonary symptoms.

C) Educate the patient on energy conservation techniques to manage fatigue effectively.

D) Monitor the patient's nutritional intake closely and collaborate with the nutritionist to ensure adequate caloric and nutrient intake.

A patient receiving immunosuppressive therapy develops a low-grade fever, mild tachycardia, and elevated inflammatory markers. Blood cultures and sputum samples have been obtained, and broad-spectrum antibiotics have been initiated. Considering her condition, what is the most appropriate nursing action to prioritize while waiting for culture results?

A) Continue monitoring vital signs and report any significant changes.

B) Immediately request an increase in corticosteroids from the healthcare provider.

C) Educate the patient about the side effects of antibiotics.

D) Initiate contact precautions to prevent the spread of infection.

A patient on immunosuppressive therapy develops a low-grade fever, mild tachycardia, and elevated inflammatory markers, suggesting a possible infection. The healthcare team initiates broad-spectrum antibiotics and considers increasing corticosteroids. What is the nurse's priority intervention in managing this patient?

A) Monitor the patient's vital signs and oxygen saturation closely.

B) Educate the patient about the importance of hand hygiene to prevent further infection.

C) Encourage the patient to increase fluid intake to assist in medication metabolism.

D) Prepare the patient for a bronchoscopy to obtain a definitive diagnosis.

A patient with bacterial pneumonia due to Pseudomonas aeruginosa is experiencing increased respiratory effort and requires supplemental oxygen. The infectious disease specialist has recommended switching to piperacillin-tazobactam. Which nursing intervention is most critical to perform after initiating the new antibiotic therapy?

B) Assess for signs of an allergic reaction to the new antibiotic.

A) Monitor the patient's respiratory rate and effort.

B) Assess for signs of an allergic reaction to the new antibiotic.

C) Check the patient's blood glucose levels regularly.

D) Encourage fluid intake to help thin secretions.

A patient with bacterial pneumonia caused by Pseudomonas aeruginosa is being treated with piperacillin-tazobactam. The patient is also receiving corticosteroids due to an underlying autoimmune condition. The nurse notes increased respiratory effort, and fine crackles are heard on auscultation. Which nursing intervention is the most appropriate at this time to prevent further respiratory compromise?

B) Position the patient in a high Fowler's position to facilitate lung expansion.

A) Increase the flow of oxygen via nasal cannula to 4 liters per minute.

B) Position the patient in a high Fowler's position to facilitate lung expansion.

C) Encourage the patient to perform incentive spirometry every hour while awake.

D) Administer a bronchodilator as prescribed to alleviate respiratory distress.

Dermatomyositis - Nursing Case Study

Pathophysiology

• Primary mechanism: Dermatomyositis is primarily an autoimmune condition where the immune system mistakenly attacks muscle fibers and skin tissues, leading to inflammation and muscle weakness. The presence of specific autoantibodies, such as anti-Mi-2, can exacerbate this immune response.

• Secondary mechanism: Complement-mediated damage occurs as part of the autoimmune attack, with activation of the complement system leading to the formation of the membrane attack complex. This process results in further muscle fiber injury and capillary damage, contributing to skin rashes.

• Key complication: Chronic inflammation and muscle damage can cause progressive muscle weakness and atrophy, significantly impacting mobility and daily functioning, while skin involvement can lead to photosensitivity and increased risk of skin infections.

Patient Profile

Demographics:

45-year-old female, office administrator

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Dermatomyositis diagnosed 6 months ago

• Current medications: Prednisone, Methotrexate, Metformin, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Progressive muscle weakness and skin rash

• Key symptoms: Difficulty climbing stairs, heliotrope rash around the eyes, Gottron's papules on the knuckles, fatigue, shortness of breath

• Vital signs: Blood pressure 145/92 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F, oxygen saturation 92% on room air

Section 1

New Complications:

Over the past few weeks, the patient has experienced worsening shortness of breath and an increased sense of fatigue, prompting further evaluation. Pulmonary function tests revealed a restrictive pattern, consistent with interstitial lung disease, a known complication of dermatomyositis. High-resolution CT scans of the chest showed ground-glass opacities and reticular patterns, indicative of early interstitial lung involvement. This finding correlates with her decreased oxygen saturation levels, which have now dropped to 89% on room air.

In addition to pulmonary complications, the patient reports new-onset dysphagia, especially with solids, suggesting esophageal involvement due to muscle weakness. A barium swallow study confirmed moderate esophageal dysmotility. These complications further complicate her nutritional status and could contribute to weight loss and malnutrition if not addressed promptly. Her lab results show elevated creatine kinase levels, reinforcing ongoing muscle inflammation, and a marginal increase in C-reactive protein, indicating systemic inflammation.

Given these new findings, the clinical team is considering adjustments to her treatment regimen. The addition of intravenous immunoglobulin (IVIG) is being discussed to potentially stabilize her immune response and mitigate further progression of interstitial lung disease. Furthermore, the team plans to consult a pulmonologist for specialized management of her lung condition and a gastroenterologist to address her esophageal symptoms, ensuring a comprehensive approach to her complex, evolving condition. These steps aim to prevent further deterioration in her respiratory function and improve her overall quality of life.

Section 2

The patient's response to the initial interventions, including the commencement of intravenous immunoglobulin (IVIG) therapy, is being closely monitored. Within the first week of treatment, there is a noted improvement in her muscle strength, with a slight decrease in creatine kinase levels, now at 950 U/L, down from 1200 U/L. Her C-reactive protein levels have also shown a minimal decrease, indicating a mild reduction in systemic inflammation. Despite these encouraging signs, her respiratory status remains a concern. Follow-up pulmonary function tests reveal persistently reduced lung volumes, with a forced vital capacity (FVC) at 55% of predicted, underscoring ongoing restrictive lung disease.

However, the patient's oxygen saturation has improved marginally to 91% on room air, suggesting a potential positive response to the IVIG in terms of stabilizing her pulmonary function. The pulmonologist has recommended the initiation of low-dose corticosteroids to further manage the interstitial lung disease, along with continued respiratory therapy to optimize lung expansion and clearance.

Meanwhile, the patient's dysphagia persists, and she continues to report difficulty swallowing solids. A repeat barium swallow study shows no significant progression of esophageal dysmotility, yet her nutritional intake is suboptimal, leading to a 5-pound weight loss over the past two weeks. The gastroenterologist has suggested dietary modifications, including a soft diet and frequent small meals, to mitigate further weight loss and support her nutritional status. The multifaceted approach by the medical team aims to address these interconnected complications, emphasizing the need for ongoing monitoring and adjustment of her treatment plan to prevent further deterioration and enhance her quality of life.

Section 3

In the subsequent days, the patient's clinical status shows mixed developments. While her muscle strength continues to improve, with her ability to perform basic activities of daily living showing marked progress, her respiratory condition warrants closer attention. The introduction of low-dose corticosteroids appears to have a stabilizing effect on her lung function, with a slight improvement in her forced vital capacity (FVC), now at 60% of predicted. Despite this, her oxygen saturation remains at 91% on room air, and she reports increased fatigue and breathlessness on exertion.

A follow-up high-resolution CT scan of the chest reveals subtle progression of interstitial changes, suggesting ongoing inflammatory activity despite the current treatment regimen. This finding prompts the multidisciplinary team to deliberate potential adjustments to her immunosuppressive therapy, considering alternative or adjunctive medications to better control her pulmonary symptoms.

Additionally, the patient's persistent dysphagia and inadequate oral intake continue to challenge her nutritional status. Her weight has decreased further, now totaling a 7-pound loss over the past three weeks. A nutritionist is consulted to develop a tailored plan incorporating high-calorie, nutrient-dense supplements, alongside the recommended soft diet. The team remains vigilant, recognizing the interconnected nature of her symptoms and the importance of proactive management to prevent further complications and optimize her overall health outcomes.

Section 4

In the following days, the patient's condition presents a new complication that requires immediate attention. During a routine assessment, the nurse observes that the patient has developed a low-grade fever of 100.8°F, along with mild tachycardia, with a heart rate of 105 bpm. Her blood pressure remains stable at 118/72 mmHg, and her respiratory rate has slightly increased to 22 breaths per minute. Given the recent interstitial changes on her CT scan and her persistent respiratory symptoms, these new findings raise concern for a possible infection or an exacerbation of her underlying condition.

Laboratory investigations, including a complete blood count and inflammatory markers, reveal a leukocytosis with a white blood cell count of 13,000/µL and elevated C-reactive protein levels. These results, coupled with her clinical presentation, suggest an inflammatory or infectious process in her lungs. Considering her immunosuppressive therapy, the team is particularly cautious about the risk of opportunistic infections. Blood cultures and sputum samples are obtained to identify any potential pathogens, and empirical broad-spectrum antibiotics are initiated to address any possible bacterial infection.

The multidisciplinary team reconvenes to evaluate the need for modifications in her treatment plan. The pulmonologist suggests increasing the dosage of corticosteroids temporarily to better control the pulmonary inflammation, while the rheumatologist considers adding a second-line immunosuppressive agent, such as azathioprine or mycophenolate mofetil, to achieve more effective disease control. The patient's nutritional status is also closely monitored, with the nutritionist adjusting her supplemental intake to support her increased metabolic demands during this acute phase. The team remains vigilant, preparing for further intervention based on the outcomes of the ongoing diagnostic tests, and plans a follow-up meeting to reassess her condition and adjust her management plan accordingly.

Section 5

As the team awaits further diagnostic results, the patient's condition unexpectedly deteriorates. During a morning assessment, the nurse notes that the patient appears more fatigued and is experiencing increased difficulty breathing, with her respiratory rate escalating to 28 breaths per minute. She has developed a dry cough and presents with accessory muscle use, suggesting increased respiratory effort. Auscultation reveals diminished breath sounds bilaterally, especially in the lower lobes, accompanied by fine crackles. Her oxygen saturation has decreased to 88% on room air, prompting the initiation of supplemental oxygen via nasal cannula at 2 liters per minute, which improves her saturation to 93%.

The latest lab results indicate a further elevation in her white blood cell count to 15,500/µL, with a left shift on the differential, and persistently high C-reactive protein levels, suggesting ongoing inflammation. Additionally, the sputum culture returns positive for a gram-negative organism, Pseudomonas aeruginosa, indicating a bacterial pneumonia. This finding necessitates a change in the antibiotic regimen to target the specific pathogen, and the infectious disease specialist recommends switching to an antipseudomonal agent such as piperacillin-tazobactam.

The team convenes to reassess the treatment strategy, balancing the need for aggressive infection control with the careful management of immunosuppression. The pulmonologist suggests continuing the increased corticosteroid dose to manage the inflammatory component, while considering the potential side effects and risks of steroid-induced complications. The decision is made to maintain close monitoring of the patient's respiratory status, with frequent reassessment of her vital signs and oxygenation, to quickly identify any further deterioration. The multidisciplinary team remains focused on the delicate balance between treating the infection and managing her autoimmune condition, knowing that her response to these interventions will guide the next steps in her care plan.